In a small Italian research lab, a team of scientists built something remarkable: a working replica of a two-year-old's brain. The child — whose name has been kept private — lives with autism spectrum disorder, and researchers at an Italian institution hoped this digital copy might finally reveal some of the biological secrets behind the condition.
They call their system FEDE, short for high FidElity Digital brain modEl. Published in PLOS Digital Health, the study combined detailed MRI scans with layers of mathematical modeling to create a virtual brain that doesn't just look like the original — it behaves like it. The researchers mapped twelve different tissue types in the child's head, from skull bone to the fatty myelin sheaths that speed electrical signals along nerve fibers. They fed this anatomical data into models that simulate how real neurons fire and communicate, then compared the simulation against the child's actual EEG recordings.
The match was striking. FEDE replicated the timing and location of brain activity with high precision, but it also surfaced something the researchers couldn't see any other way: irregularities buried deep in the brain's electrical chatter that standard scans miss entirely. One finding stood out — the digital twin showed background electrical noise running roughly 100 times higher than what's typical in a healthy brain. According to the team, this kind of noise could point to specific anomalies in how neurons transmit signals across synapses, the tiny junctions where brain cells connect.
The researchers believe this personalized approach could eventually help doctors diagnose autism earlier and tailor treatments to individual brains rather than relying on broad categories. Current brain-imaging tools tend to work in isolation — structural scans here, electrical models there — without pulling everything together. FEDE was designed to close that gap, creating a unified workflow that lets scientists examine anatomy and activity at the same time.
For now, this is just one child's brain. But the team sees FEDE as a template. If the method can be replicated across more patients, it might offer clinicians a powerful new lens for understanding neurodevelopmental conditions that affect millions of people worldwide.